Pharmacology

Action Mechanism of Action Reference
DISRUPTING AGENT Melanoma cells disrupting agent Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Melanoma 3 D008545 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Sarcoma, Kaposi 2 D012514 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Carcinoma, Intraductal, Noninfiltrating 1 D002285 ClinicalTrials
Head and Neck Neoplasms 1 D006258 ClinicalTrials
Glioma 1 D005910 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
Rectal Neoplasms 1 D012004 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108727
FDA SRS 07730V90L6